The long control region (LCR) and the E2 protein of human papillomaviruses (HPV) are the most important viral factors regulating transcription of the viral oncogenes E6 and E7. Sequence variation within these genomic regions may have an impact on the oncogenic potential of the virus. Sequence variation in the LCR and in the E2 gene of human papillomavirus type 16 (HPV-16) isolates originating from cervical cancer patients from East Hungary was studied. In 30 samples, sequencing and/or single-strand conformation polymorphism analysis revealed variants belonging to the European variant lineage of HPV-16. These variants differed from the reference European clone only slightly in their E2 and LCR sequences. Three samples represented variants belonging to the Asian-American group. These differed from the published reference sequence at several positions in the LCR and E2 regions. Compared to the reference clone, the LCR clones of the European isolates showed very similar transcriptional activities, while that of an Asian-American isolate had " 1n7-fold increased activity. Most of the increased activity of the Asian-American isolate could be ascribed to nucleotide changes found at the 3h end of the LCR (nt 7660-7890). The transcriptional transactivation potentials of the HPV-16 E2 isolates differed only slightly from each other, and the differences seemed to be independent of the taxonomic position of the isolates.
Introduction
Oncogenic human papillomaviruses etc.) are thought to be the most important risk factors in the development of cervical cancer, one of the most common female malignancies worldwide. On the other hand, low-risk HPVs etc.) are the causative agents of benign genital warts (Schneider, 1993) .
The difference in the oncogenic potential between highand low-risk HPVs was also shown by in vitro transformation studies (Woodworth et al., 1989) . The region of the papillomavirus genome required for transformation was mapped to the The GenBank accession numbers of the LCR and the E2 sequences reported in this paper are AF067024-AF067027 and AF067028-AF067035, respectively. long control region (LCR) and the E6 and E7 genes (Villa & Schlegel, 1991) . The E6 and E7 gene products of high-risk HPVs, but not of low-risk HPVs, were shown to functionally inactivate two important cellular tumour suppressors, the p53 and the pRB proteins, respectively (Dyson et al., 1989 ; Scheffner et al., 1990) . The transcription of these viral oncogenes is controlled by promoter and enhancer elements of the LCR. The LCR contains several binding sites for cellular transcription factors, which modulate its function positively (AP-1, SP-1, NFI, Oct-1, TEF-1) or negatively (YY1) (Desaintes & Demeret, 1996 ; O'Connor & Bernard, 1995 ; Turek, 1994) . The enhancer region functions in a cell type-specific fashion, i.e. activates transcription only in keratinocytes, the natural target cells of the virus (Chong et al., 1991) .
The binding motif ACCGN % CGGT of the viral transcriptional regulatory protein E2 occurs in the LCR of all HPVs (Desaintes & Demeret, 1996) . The E2 protein is composed of an N-terminal transcriptional activation domain, a central hinge region and a C-terminal region involved in DNA binding and in the dimerization of the protein (Giri & Yaniv, 1988) . The E2 protein can either activate or repress transcription from a promoter, depending on its configuration (Turek, 1994 ; Desaintes & Demeret, 1996) . In genital HPVs, the E6-E7 promoter (such as P97 in HPV-16) is rather repressed by E2, because binding of the E2 protein to its recognition sites can displace important cellular transcriptional activators (SP-1 and TFIID) from their adjacent binding sites (Tan et al., 1994) . However, one study reported the activation of HPV-16 P97 transcription in cervical keratinocytes by the homologous E2 protein when it was expressed from a weak promoter (Bouvard et al., 1994) . The E1 and E2 proteins are also required for the replication of episomal papillomavirus genomes (Chiang et al., 1992) .
There may be significant nucleotide sequence variation within HPV types. Sequence analysis of HPV-16 LCR, E6 and L1 regions has led to the classification of HPV-16 variants into five major classes : one European (E), two African (Af1 and Af2), one Asian (As) and one Asian-American (AA) (Yamada et al., 1997) . Sequence variation in the E6-E7 oncogenes and in the LCR, which controls their transcription, may have functional significance, i.e. there may be differences in the oncogenic potential of different variants. Indeed, infections caused by European HPV-16 variants were found to have a lower risk of progression to cervical intraepithelial neoplasia than those caused by the other variants (Xi et al., 1997) . In addition, certain European HPV-16 isolates from cervical cancers containing point mutations or deletions of YY1 binding sites in the LCR were found to have enhanced transcriptional activity when compared to the reference European isolate (Dong et al., 1994) .
In spite of the significant role of HPV E2 proteins in transcriptional regulation, their sequence variation has not yet been intensively studied. One study (Hecht et al., 1995) described HPV-18 E2 sequence variants, some of which were suggested to have decreased oncogenic potential. Theoretically, it is also possible that different HPV-16 E2 variants have differential effects on the transcriptional function of the LCR.
In this study, we wanted to look at the nucleotide and amino acid sequence variation within the HPV-16 E2 gene. The transcriptional transactivation function of the isolated E2 variants was also examined. In addition, the LCR regions of some HPV-16 isolates were sequenced and their transcriptional activity was evaluated.
Methods
Single-strand conformation polymorphism (SSCP) and direct sequencing. The specimens used in this study were all collected at the University Medical School of Debrecen (Hungary) from patients suffering from invasive cancer of the uterine cervix. The E2 ORF was amplified from HPV-16-positive cervical cancer specimens by PCR using the primers E2\1 (5h GCGCGAATCCAGGACGAGGACAAGGAAAA 3h ; nt 2735-2753) and E2\2 (5h GCGCGAATCCGGATGCAGTATC-AAGATTTG 3h ; nt 3854-3873) (artificial EcoRI sites used for cloning in both primers are underlined). In this PCR, a 1139 bp long amplimer was produced, which included the whole E2 gene (Das et al., 1992) . Amplification was performed with Pwo polymerase (an enzyme with proof-reading activity), according to the manufacturer's recommendations (Boehringer Mannheim). For single-strand conformation polymorphism (SSCP) analysis, the E2-positive samples were amplified in two overlapping parts, which we designated E2a and E2b. The E2a part was amplified by the primers E2\1 and E2\4 (5h GTTCGTATTCCTTCA-TGAAC 3h ; nt 3232-3252) and the resulting 518 bp product was digested by the restriction enzymes HaeIII and NsiI, resulting in restriction fragments of 253, 157 and 108 bp in length (Table 1) . The 693 bp long E2b amplimer was generated by the primers E2\2 and E2\3 (5h AGCATCAGTAACTGTGGTAG 3h ; nt 3181-3200) and digested by the enzymes HaeIII and PstI, resulting in restriction fragments of 296, 221 and 176 bp in length. Each digested amplimer (3 µl) was diluted 20i in 95 % formamide (containing 0n05 % bromophenol blue and 0n05 % xylene cyanol). Each diluted sample (30 µl) was run in 10 % native polyacrylamide gel with 1i TBE (at 5 mC and 250 V for 5 h). After electrophoresis, the DNA fragments were visualized in the gel by silver staining. The selected E2 PCR products were directly sequenced using the fmol DNA Cycle Sequencing System (Promega) with primers end-labelled with [γ-$#P]dATP according to the manufacturer's recommendations.
Plasmid constructs. For functional analysis, some HPV-16 E2 isolates were cloned into the eukaryotic expression vector pCMV1. For this purpose, the full-length E2 amplification products were digested by EcoRI, purified with the Qiaquick PCR purification kit (Qiagen), and cloned into pCMV1 vector previously digested by EcoRI. The resulting clones were sequenced with the T7 sequencing kit (Pharmacia Biotech) using α-$&S-labelled dATP and vector-specific outer and insert-specific inner primers. The LCR of HPV-16 was amplified in selected samples using the primers 16LCR1 (5h TTCTGCAGACCTAGATCAGTTTCC 3h ; nt 7003-7026 ; a natural PstI site is underlined), and 16LCR2 (5h GCGCGGTACCTTGCAGTTCTCTTTTGGTG 3h ; nt 86-104 ; an artificial KpnI site is underlined). Here, 1008 bp amplimers were produced, which included the 3h end of L1 and the whole LCR without the start codon of E6. The amplification products were digested by PstI and KpnI, purified with the Qiaquick PCR purification kit, and cloned into pUC19 vector digested by PstI and KpnI. The resulting clones were sequenced by the T7 sequencing kit, and those selected for functional analysis were subcloned into the promoterless luciferase reporter vector pALuc (Dong et al., 1994) digested by PstI and KpnI. In order to construct the chimeric reporter vector pALuc-59\33LCR, which contains the 5h half of the LCR from isolate 59 (a European variant) and the 3h half of the LCR from isolate 33 (an Asian-American variant), we isolated the PstI-DraIII fragment (nt 7003-7622) from plasmid pALuc-59LCR and inserted it into the vector pALuc-33LCR that had been previously digested with PstI and DraIII. Similarly, to construct the chimeric reporter vector pALuc-33\59LCR, which contains the 5h half of the LCR from isolate 33 and the 3h half of the LCR from isolate 59, we isolated the PstI-DraIII fragment from plasmid pALuc-33LCR and inserted it into the vector pALuc-59LCR digested with PstI and DraIII. The LCR point-mutant plasmids pALuc-7689M, pALuc-7743M and pALuc-7786M were constructed by a PCR site-directed mutagenesis protocol (Ausubel et al., 1995) , using the outer primers 16LCR1 and 16LCR2, and complementary inner primers carrying the desired nucleotide changes. These mutants were generated in the background of the reference HPV-16 LCR, using the plasmid pUC19-pt16LCR as a template. The chimeric or mutated reporter vectors were verified by sequencing.
Cell culture and transfections. The human cervical cancer cell line C-33A was maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % foetal calf serum and the antibiotics penicillin and streptomycin. The cells were transfected in 6 cm diameter dishes by the calcium phosphate method (Ausubel et al., 1995) . In order to test the transcriptional activity of the different HPV-16 LCR variants, C-33A cells were transfected with 2 µg reporter vector pALuc containing The pHPV-16 reference clone was used as a standard in the PCR-SSCP analysis. R, Same pattern as that of the pHPV-16 reference clone ; N, new SSCP pattern ; -, restriction enzyme digestion in these cases gave fragments of " 310 bp and " 160 bp instead of 296 bp and 176 bp, respectively, so these fragments could not be evaluated by SSCP. 
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* As well as isolates 936 and 995, twenty-three more specimens had the same SSCP pattern as the reference clone in each fragment.
the LCR sequences and 1 µg pRSVβ-Gal. The cells were harvested 48 h after transfection by the addition of 500 µl Reporter Lysis buffer (Promega). The Promega Luciferase Assay system was used to measure luciferase activity of cell extracts. A β-galactosidase assay was also performed to standardize for transfection efficiency. To evaluate the transactivation potential of the different E2 variants, we used the reporter constructs pC18Sp1-Luc or pALuc-pt16LCR. The former, which was kindly provided by Gertrud Steger (Department of Virology, University of Cologne, Cologne, Germany) contains four E2 binding sites, two Sp1 binding sites and expresses the firefly luciferase gene under the influence of the adenovirus major late promoter. The reporter construct pALucpt16LCR contains the whole HPV-16 LCR cloned directly upstream of the luciferase gene. C-33A cells were co-transfected with 2 µg of either reporter construct, 1 µg eukaryotic expression vector pCMV1, containing the different HPV-16 E2 variant sequences, and 1 µg pRSVβ-Gal. The amount of DNA transfected was kept constant by the addition of the empty expression vector pCMV1.
Results

PCR-SSCP analysis of the HPV-16 E2 region
The cervical cancer specimens used in this study were all collected at the University Medical School of Debrecen from patients living in East Hungary. In order to analyse nucleotide sequence variation in the HPV-16 E2 region, the E2 ORF was amplified in 33 samples and the amplification products were subjected to SSCP analysis. In SSCP tests, short DNA fragments are denatured and electrophoresed in native polyacrylamide gel, in which they acquire a secondary structure dependent on the nucleotide sequence. Different sequence variants run to different positions in the gel on the basis of their secondary structure (Xi et al., 1993) .
For SSCP analysis, the E2 gene was amplified in two overlapping parts (designated E2a and E2b), and both were digested with appropriate restriction enzymes to give small DNA fragments (see Methods). The E2a and E2b regions were analysed in separate gels, and each sample was run at least twice. Amplification products of the pHPV-16 reference clone were included in each gel as standards ; the SSCP patterns obtained from the samples were compared to these. The results of SSCP analysis are summarized in Table 1 . From the 33 samples analysed, 25 (76 %) had the same SSCP pattern in each E2 fragment as the pHPV-16 reference clone, and only eight samples differed from the standard in any one fragment. Of these, three samples (nos 33, 962 and 972) differed from the reference after restriction enzyme digestion by HaeIII and PstI. In these cases, the 296 and 176 bp fragments were replaced by fragments of " 310 bp and " 160 bp in length, respectively, so these fragments could not be evaluated by SSCP. In any case, these three samples differed most from the reference clone : three out of four E2 fragments obtained had SSCP patterns that differed from those of the standard.
Sequence analysis of HPV-16 E2/E4 and LCR variants
On the basis of SSCP analysis, ten specimens were selected for sequencing of the E2 ORF : two with SSCP patterns identical with the reference clone, and eight with new SSCP patterns. In addition, the E2 coding region of the reference clone pHPV-16 was amplified, sequenced and cloned for use in functional tests. The complete E2 ORF was amplified in the selected samples and the amplification products were se- quenced directly. On the other hand, the full-length E2 amplimers were cloned into the eukaryotic expression vector pCMV1, and the resulting clones were sequenced again to exclude the possibility of sequence alterations introduced by amplification.
BADH
The results of sequence analysis performed within the E2 gene region are summarized in Table 2 . Here, only those nucleotide and amino acid positions where alterations were found from the published sequence of the reference clone (Seedorf et al., 1985) are shown. The numbering of nucleotide positions is based on the revised sequence of HPV-16 (HPV-16R) available in the HPV Sequence Database (Los Alamos National Laboratory). No deletions or insertions in the E2 ORF were found in any isolate. The reference clone was found to have an A-to-G change at nt 2926 and all the sequenced isolates had the same transition, so the A at nt 2926 may have been a sequencing error in the original publication. Another frequent alteration from the reference sequence was found at 
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* GRE, Glucocorticoid\progesterone response element ; TEF-1, transcription enhancing factor 1 ; NFI, nuclear factor 1.
nt 3410, where eight out of ten sequenced isolates had a C-to-T change, which resulted in the substitution of serine for proline at aa 219. Altogether, 30 nucleotide and 20 amino acid changes were found in the E2 gene compared with the reference sequence. Only a small number of nucleotide or amino acid changes were found in seven out of ten sequenced isolates, and these were found to belong to the European variant lineage of HPV-16 after sequence analysis of the LCR (see below). Three isolates (nos 33, 962 and 972) had 22-23 nucleotide and 16 amino acid changes (this corresponds to 2n1 % nucleotide and 4n4 % amino acid alteration from the reference sequence) ; later, these isolates were found to belong to the Asian-American variant group. The E4 ORF overlaps the central part of the E2 ORF in a different reading frame, so the nucleotide changes found also resulted in some amino acid changes in the E4 protein. However, the same nucleotide changes resulted in fewer changes at the amino acid level in the E4 ORF. The E4 region contained only three amino acid changes and a stop codon (at aa position 74 in isolate 982), whereas the corresponding region of the E2 ORF contained a total of nine amino acid changes (data not shown)
In order to determine the taxonomic position of our HPV-16 isolates, we decided to sequence the LCR. The complete LCR was amplified, cloned and sequenced from seven samples, of which five were also analysed in the E2 region. Two more samples (nos 926 and 957) were chosen because they contained episomal HPV-16 DNA, which was reported to have frequent sequence alterations in cervical cancer samples (Dong et al., 1994) .
The sequence alterations found in our HPV-16 LCR clones are shown in Table 3 . Here, the revised sequence of HPV-16 (HPV-16R in the HPV Sequence Database) was used as a reference and the nucleotide numbers also refer to this. The HPV-16R sequence contains the following differences in the LCR from the original published sequence (Seedorf et al., 1985) : substitution of ' cgg ' for ' gc ' at nt 7434, and deletion of ' a ' at nt 7863 (nucleotide positions are given in terms of the corrected sequence). These two sequence alterations were also found in both the reference clone and in all our sequenced isolates, so these are not presented in Table 3 . After comparing the LCR sequences of our isolates with the results of Yamada et al. (1997) , we found that isolate 33 (and also isolates 962 and 972) belonged to the Asian-American variant group of HPV-16. On the basis of sequencing (in the LCR and\or E2) and SSCP analysis, the other 30 isolates analysed in this study proved to be European variants.
Functional analysis of HPV-16 LCR and E2 variants
Some nucleotide changes found in our HPV-16 LCR isolates involved known binding sites for cellular transcription factors or the glucocorticoid\progesterone receptor (Table 3) . In isolate 936, a G-to-T change at nt 7716 occurred in one of the seven known binding sites of the HPV-16 LCR for nuclear factor 1 (NFI) (Chong et al., 1991) . In isolate 33, nucleotide changes were found in two of the three known glucocorticoid\ progesterone response elements (GRE), and in one of two proven binding sites for transcription enhancing factor 1 (TEF-1) (Mittal et al., 1993 ; Ishiji et al., 1992) . The effects of these nucleotide changes on the activity of the binding sites is unknown as yet.
To study the functional significance of sequence alterations found in the HPV-16 LCR variants, the complete LCR sequences from isolates 33, 59, 936 and 957 (and from the reference clone) were subcloned into the promoterless luciferase reporter vector pALuc. The resulting reporter constructs were transfected into C-33A cells and transcriptional activities were analysed 48 h later by luciferase tests (Fig. 1) . All the European variants had very similar activities to that of the control, while the Asian-American isolate 33 had " 1n7-fold increased activity (P 0n01).
In an effort to localize the region responsible for the enhanced transcriptional activity of the Asian-American variant, we constructed two chimeric vectors. The pALuc-59\33LCR construct contains the 5h half of the LCR (nt 7003-7622) from isolate 59 (a European variant) fused to the 3h half of the LCR (nt 7623-104) from isolate 33 (an Asian-American variant). The pALuc-33\59LCR construct contains the 5h half of the LCR (nt 7003-7622) from isolate 33 fused to the 3h half of the LCR (nt 7623-104) from isolate 59. These constructs were also tested in transient transfection assays and the results are shown in Fig. 1 . The vector pALuc-33\59LCR had only slightly greater activity than pALuc-59LCR, while the activity of pALuc-59\33LCR was very close to that of the construct pALuc-33LCR. This shows that most of the enhanced activity of the Asian-American LCR variant can be ascribed to nucleotide changes found in the 3h half of the LCR (after nt 7622). In order to map the nucleotide changes responsible for the slightly enhanced transcriptional activity of the isolate 33 LCR variant, we generated point mutations by PCR site-directed mutagenesis in the background of the reference clone pALucpt16LCR, and tested the mutated constructs in transient transfection experiments. The clones pALuc-7689M, pALuc-7743M and pALuc-7786M contain the point mutations found at the corresponding nucleotide positions in the LCR sequence of isolate 33 (see Table 3 ). The pALuc-7689M vector contains a mutation in a TEF-1 binding site (Ishiji et al., 1992) , which may change the binding abilities of this site. In pALuc-7743M, an Oct-1-NFI composite regulatory element (O'Connor & Bernard, 1995) is altered in such a way that one base of a 2 bp spacer element between the two binding motifs is changed. In pALuc-7786M, the nucleotide change generated occurs be- tween two binding sites for the YY1 transcription factor (O'Connor et al., 1996) . Data obtained with these mutated constructs are shown in Fig. 1 . It can be seen that each nucleotide change resulted in only slightly enhanced transcriptional activity of the HPV-16 LCR. The clone pALuc-7689M had the highest activity compared to the reference LCR clone, but the difference between them was not statistically significant. To study the intrinsic transactivation function of our HPV-16 E2 isolates, we cloned them into the eukaryotic expression vector pCMV1. C-33A cells were co-transfected with the E2 expression vectors and the reporter construct pC18Sp1-Luc. This construct contains four E2 binding sites, two Sp1 binding sites and the firefly luciferase gene driven by the adenovirus major late promoter, and it can be efficiently transactivated by papillomavirus E2 proteins. When increasing amounts of the E2 expression vector pCMV-pt16E2 containing the reference HPV-16 E2 coding sequences were co-transfected with 2 µg reporter construct pC18Sp1-Luc, a dose-dependent transactivation effect was seen (Fig. 2. ). Next, we tested all six HPV-16 E2 isolates with different amino acid sequences, using 1 µg E2 expression vector and 2 µg reporter construct (Fig. 3 a) .
Although there were some reproducible differences in the transactivation potential of the different E2 isolates, these differences were not too high. For example, the luciferase activity of the reporter construct was induced about 11-fold by the reference E2 clone pCMV-pt16E2 and 15-fold by pCMV-33E2, which contains the E2 gene of an Asian-American HPV-16 isolate (P 0n05).
Next, we examined how the transcriptional activity of the P97 early HPV-16 promoter in the context of the homologous LCR was modified by the HPV-16 E2 variants. Here, the reporter construct pALuc-pt16LCR was used, which contains the whole HPV-16 LCR cloned directly upstream of the luciferase gene (Fig. 2) . Transcription from the P97 promoter was increased slightly (" 1n5-fold) by each HPV-16 E2 variant, and no significant difference was found between the different variants (Fig. 3) .
We also tested whether the isolate 33 E2 variant had some specific effect on the LCR construct of the same variant (pALuc-33LCR) different from that on the reference LCR construct (pALuc-pt16LCR). While the constitutive level of transcription was higher in the variant LCR construct as compared to the reference LCR construct (see above), the reference E2 clone and the isolate 33 E2 clone had similar transactivation effects on both reporter constructs (data not shown).
Discussion
In this study, we have analysed sequence variation in HPV-16 isolates from cervical cancer patients living in Hungary. Out of 33 HPV-16 isolates analysed by SSCP and sequencing, 30 were found to belong to the European variant lineage and three were shown to be Asian-American variants (Yamada et al., 1997) .
The E2 gene was chosen to be analysed in detail because the products of this gene have significant roles in regulating the transcription of the viral oncoproteins E6 and E7. In addition, the E2 protein is also involved in replication of the viral episomal DNA. Papillomavirus E2 proteins were reported to down-regulate the major early promoters of genital HPVs involved in the transcription of the E6 and E7 oncogenes. On the other hand, the E1 and\or E2 gene regions of oncogenic HPV types were shown to be inactivated through integration of the viral genome into host DNA, which is a frequent event in carcinogenesis (Das et al., 1992) . It was suggested that this mechanism has a major role in the up-regulation of the early HPV promoters in cervical cancer. We speculated that certain genetic changes (deletions or point mutations) in the E2 gene might lead to the up-regulation of HPV transcription in cervical cancers carrying HPV genomes with intact and transcriptionally active E2 regions.
Nucleotide and amino acid sequence variability in the HPV-16 E2 region was found to be relatively low in our samples. No deletions or insertions were found in any of the samples. In BAEB G. Veress and others G. Veress and others addition, most of the isolates (25 out of 33) had the same SSCP pattern as the reference clone, which is a European isolate. Five additional European isolates had altered SSCP patterns, but sequence analysis revealed only a few nucleotide and amino acid changes in these compared to the reference sequence. The three Asian-American isolates had several nucleotide and amino acid changes in the E2 region compared to the reference sequence. However, none of the amino acid changes that were found occurred at positions which are conserved among the HPVs (data not shown). Similarly, there were only slight differences in the transactivation properties of our different E2 isolates in transient transfection assays. When a reporter construct containing E2 binding sites in an enhancer configuration relative to an adenovirus promoter was used, most E2 variants had similar transactivation properties (the reporter was induced 10-12-fold). The Asian-American E2 variant had a slightly enhanced transactivation effect compared to that of the European variants, but this difference may have no biological significance. The E2 variants very slightly stimulated (1n5-fold) a reporter construct containing the homologous HPV-16 LCR with the natural promoter and enhancer elements. Here, no significant difference was found between the European and Asian-American E2 variants.
These findings may point to the importance of the transactivation function of E2. However, it is also possible that conservation of the replication function of E2 was more important and the two functions bound to the same protein domains were conserved together. Although certain mutations can be introduced into the transactivation domain of E2 through which the transactivation and replication functions can be separated (Sakai et al., 1996) , it is possible that such mutations do not exist or are very rare in natural HPV isolates.
In the E4 ORF, which overlaps the central part of the E2 ORF in another reading frame, the same nucleotide changes resulted in fewer amino acid changes than in E2. It may be that amino acid changes at these positions are not tolerated in the E4 protein because of functional constraints. The exact function of the E4 protein is not known. Although its ORF resides in the early region of the genome, it is expressed in the late stage of the virus life-cycle. The E4 protein of HPV-16 was reported to induce the collapse of the cytokeratin matrix of infected keratinocytes (Doorbar et al., 1991) .
In selected HPV-16 isolates, the LCR was also sequenced and the functional significance of sequence variation studied in transient transfection assays. Similarly to the E2 region, the LCR of European variants contained only a few nucleotide changes and the transcriptional activities of these variants were very similar to that of the reference clone. In contrast, the Asian-American isolate had several nucleotide changes and it had " 1n7-fold increase in transcriptional activity compared to the reference clone. This suggests that the Asian-American variants may have enhanced oncogenic activity in comparison with the European isolate. It is also possible that the E6 and E7 proteins of non-European variants have increased intrinsic oncogenic potential. The results of Xi et al. (1997) revealed that infections caused by these variants have an increased tendency to progress. On the other hand, the E6 protein of an Asian-American HPV-16 isolate was found to induce more differentiation-resistant colonies than the reference E6 protein in human foreskin keratinocytes (Sto$ ppler et al., 1996) .
In order to localize the region responsible for the enhanced transcriptional activity of the Asian-American LCR clone, we made chimeric constructs containing LCR sequences from a European and an Asian-American clone. Transient transfection analysis revealed that most of the increased activity of the Asian-American isolate maps to the 3h half of the LCR (between nt 7660 and 7890). Altogether seven nucleotide changes were found in this region of the Asian-American LCR variant when compared to the prototype sequence. Three nucleotide changes were chosen to be analysed because they were either within or very close to transcription factor binding sites. These nucleotide changes were generated in the background of the HPV-16 LCR reference clone and tested in transient transfections. Neither of the tested nucleotide changes seemed to be responsible in itself for the enhanced transcriptional activity of the Asian-American LCR variant. Rather, we think that a combination of nucleotide changes in the corresponding LCR region could be responsible for the observed functional change. It is of interest that a nucleotide change in a TEF-1 binding site in the clone pALuc-7689M did not result in reduced transcriptional activity, even though TEF-1 is an activator of HPV-16 transcription (Ishiji et al., 1992) . It is possible that this nucleotide change results in enhanced affinity of TEF-1 to the altered binding site. Alternatively, there may be a negative factor binding site overlapping with this TEF-1 site, and the nucleotide change may result in reduced binding of the negative factor. Gel shift analyses with nuclear extracts and purified TEF-1 protein will be necessary to test these possibilities.
In the Asian-American LCR variant, nucleotide changes were also found in two of the three known GRE of HPV-16 LCR. Although these changes did not result in significantly increased basic transcriptional activity (as seen with the chimeric constructs), inducement by progesterone hormone might reveal some additional functional differences between European and other HPV-16 variants.
In conclusion, sequence variation in the HPV-16 E2 region does not seem to be a major mechanism in the up-regulation of transcription from the P97 early promoter of HPV-16. In contrast, sequence changes in the LCR can lead to an enhanced transcription of the E6 and E7 oncogenes (Dong et al., 1994 ; Chen et al., 1997 ; this study) . On the other hand, sequence variability in these viral oncogenes themselves may also have functional significance, as suggested by some in vitro and in vivo studies (Sto$ ppler et al., 1996 ; Zehbe et al., 1998) .
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